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conjugates
Abstract
We report a simple one step protocol for the preparation of fairly monodisperse and highly water-soluble
magnetic iron oxide nanoparticles (MIONs) through a co-precipitation method using a novel
multifunctional, biocompatible and water-soluble polymer ligand dodecanethiol-polymethacrylic acid (DDT-
PMAA). DDT-PMAA owing to its several intrinsic properties, not only efficiently controls the size of the
MIONs but also gives them excellent water solubility, long time stability against aggregation and oxidation,
biocompatibility and multifunctional surface rich in thioether and carboxylic acid groups. The molecular
weight and concentration of the polymer ligand were optimized to produce ultrasmall (4.6 +/- 0.7 nm)
MIONs with high magnetization (50 emu g(-1)). The MIONs obtained with 1.5 mM DDT-PMAA (5330 g
mol(-1)) are highly stable in solution as well as in dry powder form for an extended period of time. These
MIONs show a high degree of monodispersity and are superparamagnetic at room temperature. The polymer
ligand and MIONs@Polymer were characterized by GPC, H-1 NMR, DLS, TEM, FTIR-Raman, XRD, TGA
and VSM. In order to demonstrate the bio-applications of these magnetic nanoparticles (NPs), their toxicity
was determined by MTT assay and they were found to be non-toxic and biocompatible. Finally, MIONs were
conjugated with the anti-cancer drug doxorubicin (DOX) and its efficacy, as a model drug delivery system,
was determined using HepG2 cells. The efficiency of the drug-NP conjugates i.e., covalently bound DOX-
MIONs and electrostatically loaded DOX/MIONs, was found to be significantly higher than that of the free
drug (DOX).
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Highly water-soluble magnetic iron oxide (Fe3O4)
nanoparticles for drug delivery: enhanced in vitro
therapeutic efficacy of doxorubicin and MION
conjugates†
Muhammad Irfan Majeed,a Qunwei Lu,b Wei Yan,*af Zhen Li,c Irshad Hussain,*d
Muhammad Nawaz Tahir,e Wolfgang Tremele and Bien Tan*a
We report a simple one step protocol for the preparation of fairly monodisperse and highly water-soluble
magnetic iron oxide nanoparticles (MIONs) through a co-precipitation method using a novel
multifunctional, biocompatible and water-soluble polymer ligand dodecanethiol–polymethacrylic acid
(DDT–PMAA). DDT–PMAA owing to its several intrinsic properties, not only efficiently controls the size
of the MIONs but also gives them excellent water solubility, long time stability against aggregation and
oxidation, biocompatibility and multifunctional surface rich in thioether and carboxylic acid groups. The
molecular weight and concentration of the polymer ligand were optimized to produce ultrasmall (4.6 
0.7 nm) MIONs with high magnetization (50 emu g1). The MIONs obtained with 1.5 mM DDT–PMAA
(5330 g mol1) are highly stable in solution as well as in dry powder form for an extended period of
time. These MIONs show a high degree of monodispersity and are superparamagnetic at room
temperature. The polymer ligand and MIONs@Polymer were characterized by GPC, 1H NMR, DLS, TEM,
FTIR-Raman, XRD, TGA and VSM. In order to demonstrate the bio-applications of these magnetic
nanoparticles (NPs), their toxicity was determined by MTT assay and they were found to be non-toxic
and biocompatible. Finally, MIONs were conjugated with the anti-cancer drug doxorubicin (DOX) and its
efficacy, as a model drug delivery system, was determined using HepG2 cells. The efficiency of the drug–
NP conjugates i.e., covalently bound DOX–MIONs and electrostatically loaded DOX/MIONs, was found
to be significantly higher than that of the free drug (DOX).
1 Introduction
Magnetic NPs have gained much scientic interest for their
unique magnetic properties such as superparamagnetism, high
coercivity, low Curie temperature, and high magnetic suscepti-
bility.1,2 Magnetic iron oxide nanoparticles (MIONs), owing to
their advantages such as low toxicity and biocompatibility, are
considered to be the most favourable candidate for bio-applica-
tions3 including magnetic resonance imaging (MRI),4,5 magnetic
uid hyperthermia (MFH),6 magnetic separation and immobili-
zation of biomolecules such as nucleic acids and proteins,7
development of drug delivery systems for controlled release of
drugs,8,9 biolabeling and magnetic sensors.10 Thermal decom-
position and co-precipitation are among the most common
techniques employed for MIONs preparation owing to their
advantages but these are still associatedwith some limitations.2,11
Thermal decomposition of organo-metallic iron precursors
at elevated temperatures in organic solvents and subsequent
oxidation lead to highly monodisperse MIONs with high satu-
ration magnetization because of separate nucleation and
growth processes.12–14 However these NPs are not dispersible in
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water and thus cannot be directly used for bio-applications. For
such applications they require laborious post-synthesis ligand
exchange procedures15,16 which sometimes result in aggregation
and loss of magnetic properties.17
Co-precipitation methods, however, result in the production
of water-soluble magnetic NPs and are relatively cost-effective
compared to the thermal decomposition methods. The
magnetic NPs formed are, however, usually polydisperse and
require cumbersome post-synthesis size selection proce-
dures.2,18 The polydispersity of the NPs is due to less control over
complex hydrolysis reactions of the iron precursors and diffi-
culty in the isolation of nucleation and growth steps. Further-
more, NPs obtained using co-precipitation methods oen
exhibit low crystallinity and low saturation magnetization due
to low reaction temperature.19 Therefore it is still desired to
develop simple, one step, cost effective and environmentally
friendly protocols for the preparation of water-soluble, uniform,
multifunctional, superparamagnetic iron oxide NPs with a
better control over their size, shape and magnetic properties.
Multifunctional water-soluble polymers as capping ligands
canplay an important role in thepreparationofMIONs andother
inorganic NPs.20–22 In an aqueous co-precipitation process,
polymer ligands can efficiently control the size and shape of the
NPs due to the presence of abundant functional groups such as
–COOH, –OH, –NH2 etc. These multifunctional polymers render
magnetic NPs more stable, water-soluble and uniform in addi-
tion to providing them with rich surface chemistry which opens
up ways for their easier post-synthesis modication and func-
tionalization for bio-applications.5,19,23–25Numerous studies have
been reported for the synthesis of MIONs using polymer ligands
in order to render them water-soluble and biocompatible.
However, inmost of the cases, theNPs arerst prepared through
thermal decomposition and then made water-soluble through
post-synthesis modication processes such as ligand exchange
using water-soluble polymer ligands.26
Previously we have reported the synthesis of water-soluble
magnetic iron oxide NPs (MIONs, D ¼ 4.5  0.4 nm) using a
multifunctional water-soluble polymer ligand (PTTM–PMAA)
through a co-precipitation method.19 It was found that the ratio
between carboxylic acid groups present in the polymer ligand
and iron precursors played an important role in determining
the size and particle size distribution of the MIONs. Further-
more, by exploiting the free thiol (–SH) and carboxylic acid
(–COOH) functional groups of the polymer ligand, post-
synthesis modication of these NPs led to water-soluble uo-
rescent magnetic NPs through coupling with uorescent dyes.
Recently, we have successfully described the application of
these ultrasmall MIONs as efficient positive and negative dual
contrast agents inmagnetic resonance imaging (MRI).5The in vitro
and in vivo results demonstrated their better performance over
clinically used gadolinium based T1-positive (Gd-DTPA) and iron
oxide based T2-negative (SHU-555C) contrast agents. TheseMIONs
have shown great potential as a better alternative to these single
contrast agents especially to Gd-based T1-positive contrast agents
which have known clinical risks due to gadolinium toxicity.5
Herein we report a single step synthesis of highly water-
soluble and ultrasmall (4.6  0.7 nm) MIONs using a new
thioether end-functionalized polymer ligand dodecanethiol–
polymethacrylic acid (DDT–PMAA). The effect of concentration
and molecular weight of the polymer on the size and magnetic
properties of the MIONs was also studied. A few modications
were made to our original high temperature single step co-
precipitation method19 in order to improve the magnetic prop-
erties of MIONs, such as iron precursors were dissolved in
concentrated HCl instead of 1 M HCl solution in order to
prevent their hydrolysis and condensation before the addition
of precipitating agents and the inert conditions were main-
tained, by nitrogen gas bubbling, throughout the course of
reaction which not only protects MIONs from critical oxidation
but also keeps their size smaller.27
MIONs prepared using DDT–PMAA have several carboxylic
acid (–COOH) functional groups which give them excellent
solubility and stability in aqueous solutions. These MIONs
showed high resistance against aggregation in aqueous media
over a wide range of pH and salt concentrations due to excellent
electrostatic and steric stabilization provided by the polymer
ligand. TheseMIONs canbe dried by evaporating the solvent and
stored as powder for several months without any undesired
changes in their chemical and physical properties. The polymer
ligand offers MIONs better chemical stability against oxidation
which otherwise leads to a decrease in theirmagnetic properties.
Furthermore, cytotoxicity analysis of the MIONs proved them to
be biocompatible even at high concentrations up to 500mgmL1.
The bio-applicability of these NPs was demonstrated by conju-
gating these MIONs with the anti-cancer drug doxorubicin and
studying the efficacy of these drug–NP conjugates by incubating
them with HepG2 cells, through MTT-assay. These drug–NP
conjugates were found to have a better anti-cancer drug activity
than that of the free drug. The improved drug activity in the case
of drug–NP conjugates may be due to active NPs cellular uptake
through endocytosis compared to the simple diffusion in the
case of free drug. Finally, it was concluded thatMIONs stabilized
with DDT–PMAA are extremely biocompatible and can be used
for several bio-applications due to their chemically rich surface
providing numerous possibilities for their conjugation with a
variety of therapeutic, targeting, and labelling agents.
2 Experimental
2.1 Materials
All chemicals were of analytical grade and used as-received
without any further purication, unless otherwise described.
Methacrylic acid (MAA, 99%), 2,20-azobisisobutyronitrile (AIBN,
98%), anhydrous ethanol, anhydrous acetone and anhydrous
diethyl ether were purchased from National Medicines Corpo-
ration Ltd. of P.R. China. Dodecanethiol (DDT, 99%) was
obtained from Aldrich. Ferric Chloride (FeCl3$6H2O, 99%),
ferrous sulfate (FeSO4$7H2O, 99%), hydrochloric acid (HCl,
38%) and ammonium hydroxide (NH4OH, 28%) were obtained
from Sinopharm Chemical Reagent Co. Ltd. Doxorubicin
hydrochloride was obtained from Pzer Inc. N-(3-Dimethyla-
mino-propyl)-N0-ethylcarbodiimide hydrochloride (EDC) and
N-hydroxysuccinimide (NHS) were purchased from Aladdin
Reagent Co., Ltd. (Shanghai, China). Fetal bovine serum (FBS)
This journal is ª The Royal Society of Chemistry 2013 J. Mater. Chem. B, 2013, 1, 2874–2884 | 2875
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and Dulbecco's modied eagle's medium (DMEM) were
obtained from Gibco (Basel, Switzerland). The 3-(4,5-dime-
thyltetrazolium bromide) (MTT) cell proliferation assay kit was
received from Amresco (USA). Milli-Q water was used in the
preparation and subsequent application experiments.
2.2 Synthesis and characterization of the polymer ligand
DDT–PMAA was synthesized by the chain transfer method using
thiol as a chain transfer agent as described in previous
reports.28,29 The molar ratio of the monomer to the chain
transfer agent was altered in order to prepare four different
molecular weight polymer samples. Detailed polymer ligand
synthesis procedure and characterization results are provided
in the ESI.† 1H NMR spectra were recorded on a 400MHz Bruker
AV400 spectrometer using d6-DMSO as a solvent in a 5 mm
quartz NMR tube at room temperature using the d scale and
were consistent with the previous reports.28,29
2.3 Preparation of MIONs
The MIONs synthesis process was adopted from our previous
work with little modication.19 A typical procedure involves the
co-precipitation of an aqueous iron precursor solution with
ammonia in the presence of a polymer ligand at high temper-
ature (Scheme 1). Brief experimental details of the MIONs
synthesis using the polymer ligand DDT–PMAA are provided in
the ESI under Section ESI-3.†
Twenty different samples of MIONs were prepared in the
same way but with ve different concentrations (0.25, 0.5, 1, 1.5
and 2 mM) of four different polymer ligands (0.5% DDT–PMAA,
2% DDT–PMAA, 5% DDT–PMAA and 10% DDT–PMAA having
molecular weights 14 624, 5330, 3123 and 2282 g mol1
respectively), in order to obtain MIONs with optimum size and
magnetic properties.
2.4 Characterization of MIONs
The particle size of the MIONs was determined by a high
performance particle sizer (Brookhaven Nano DLS 90Plus/BI-
MAS) with multi-angle particle sizing option (from Brookhaven
Instruments Co. USA) with an effective detection capability of 0.6
to 6000 nm. The zeta potential values were determined by a
BrookhavenZetaPlus (Brookhaven InstrumentsCo.USA) at 25 C
using the folded capillary cells. Data were obtained using a
monomodal acquisition and was t according to the Smo-
luchowski theory. Aer ltration with an aqueous membrane
(F ¼ 13 mm, 0.22 mm), the samples were analyzed using
Scheme 1 Graphical representation of the synthesis of DDT–PMAA functionalized MIONs and their subsequent conjugation with DOX.
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ultrapure water as a solvent (pH¼ 7). Thesemeasurements were
run at least three times with independent particle batches.
Transmission electron microscopy images were recorded on a
JEOL-2100 electron microscope operating at an acceleration
voltage of 200 kV. TEM samples were prepared by the slow
evaporation of a drop of dilute aqueous solution of MIONs onto
carbon-coated copper grids (400 mesh). The images were recor-
ded with a Gatan 794 CCD camera. Size distribution graphs were
prepared by analyzing about 200 individual NPs on each TEM
image by ImageJ soware. X-ray diffraction (XRD) was recorded
on an X'Pert PRO XRD spectrometer (PANalytical B.V., Holland)
using Cu Ka (l ¼ 1.54056 Å) radiation in the 2q range of 10–80.
The UV-vis spectra were recorded using a Lambda 35 UV-vis
spectrophotometer (Perkin-Elmer, U.S). The infrared spectra
were recorded by a Fourier transform infrared (FTIR) spec-
trometer (Bruker Vertex 70) equipped with an attenuated total
reection (ATR) accessory. Raman spectra were recorded on a
HR JOBIN YVON spectrometer using a laser of 632 nm and a
25% lter. Thermogravimetric analysis (TGA) measurements
were performed using a TGA Q500 at a heating rate of 10 C
min1 from room temperature to 900 C in an oxygen free
atmosphere. The saturation magnetizations (Ms) of the MIONs
were measured at 300 K on a Lakeshore 7400 Series vibrating
sample magnetometer (VSM). All the magnetization data were
normalized to the same weight.
2.5 Toxicity analysis of MIONs
Toxicity analysis of the MIONs was carried out before their bio-
application by MTT-assay using rat macrophage and HepG2
cells. The details of cell culturing andMTT-assay are provided in
the ESI under Section SI-6.†
2.6 Bio-applications of MIONs
2.6.1 Synthesis of covalent conjugates (DOX–MIONs). DOX
was covalently linked to MIONs via the formation of an amide
bond between the carboxyl groups at the surface of MIONs and
the amino groups of DOX through EDC coupling reaction.
Briey, the carboxyl groups ofMIONs were rst activated by NHS
andEDC in thePBS (0.1M, pH7.4) solution at roomtemperature.
DOX was then added and the pH of the reaction mixture was
adjusted to 8.0 with dilute aqueous NaOH solution. The reaction
was continued for 24 h in the dark with magnetic stirring. Then,
excess reactants were removed by extensive dialysis against
deionized water. The DOX conjugated MIONs were obtained by
lyophilization and stored at 4 C for further use.
2.6.2 Synthesis of electrostatic conjugates (DOX/MIONs).
The non-covalent or electrostatic loading of DOX to MIONs was
achieved through the electrostatic interaction between the
carboxyl group of MIONs and the amine group of DOX.
Specically, MIONs and DOX were mixed in water at appro-
priate pH under stirring for 12 h in the dark. The DOX/MIONs
was puried with magnetic separation and subjected to lyoph-
ilization to obtain DOX/MIONs powder.
2.6.3 Determination of drug loading efficiency. In order to
determine the drug loading efficiencies of the drug–NP
conjugates, a series of standard solutions of DOX was prepared
in buffer (pH ¼ 7.4) and a standard curve was plotted between
the concentration (along X-axis) and absorbance (along Y-axis)
with the help of a UV-visible spectroscope at lmax ¼ 480 nm.
Drug–NP conjugates were magnetically separated from the
reaction mixture and were redispersed in the buffer again. The
DOX concentration in supernatant uids as well as in redis-
persed conjugate solutions was determined from the standard
curve equation and drug loading efficiencies of drug–NP
conjugates were calculated according to the following
equation:
drug loading efficiency (%) ¼ DIC/DLC  100
where DIC is the initial concentration of DOX applied while DLC
is the concentration of loaded DOX on drug–NP conjugates.
2.6.4 Cytotoxicity analysis of drug–NP conjugates. HepG2
(human hepatoblastoma) cells are usually used for cancer and
apoptosis studies. In this study, HepG2 cells were used as the
model cancer cell line in order to demonstrate the cytotoxicity of
drug and MION conjugates. HepG2 cells were cultured in
DMEM supplemented with 10% FBS, streptomycin (100 mg
mL1) and penicillin (100 U mL1). The cells were seeded at a
density of 1  104 cells per well in 200 mL of DMEM containing
10% FBS in 96-well microtiter plates and incubated for 24 h.
Media were replaced by fresh serum free DMEMmedia (180 mL),
and drug and drug–NP conjugate solutions were added to the
culture media with nal and equivalent DOX concentrations (5,
10, 25, 50 and 100 mg mL1). Aer 24 h of incubation, culture
media were removed, and the cells were rinsed with PBS. The
cells were then incubated with MTT (0.5 mg mL1 in 200 mL of
supplemented serum free DMEM) at 37 C for 4 h. Thereaer,
the media were discarded and 150 mL of DMSO was added to
each well, and the plates were shaken for 15 min on a horizontal
shaking bath at 37 C. The absorbance wasmeasured at 490 nm.
The sample-untreated cells in the medium were used as a
positive reference. The cell viability (%) was calculated accord-
ing to the following equation:
cell viability (%) ¼ OD490 (sample)/OD490 (control)  100
MTT-assay was performed in order to determine the cyto-
toxicity of the drug–NP conjugates. Similarly, MTT-assays were
performed aer 48 and 72 h to determine the effect of incuba-
tion time period on activity of the drug–NP conjugates specu-
lated indirectly from cell viability.30
3 Results and discussion
3.1 Synthesis and characterization of the polymer ligand
A series of polymer ligand DDT–PMAA, with four different
molecular weights, was synthesized using dodecanethiol as a
chain transfer agent by free radical polymerization of the
monomer methacrylic acid (MAA) as described previously
(Scheme S1†). GPC elution curves of four different polymer
samples are shown in Fig. S1† and their molecular weights are
given in Table S1.†
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3.2 Preparation and characterization of polymer stabilized
MIONs
MIONs were synthesized by co-precipitation of an aqueous iron
precursor solution containing Fe3+ and Fe2+ (molar ratio 2 : 1)
with ammonia in the presence of DDT–PMAA. The size, shape
andmagnetic properties of the MIONs were controlled, by using
different molecular weights and concentrations of the polymer
ligand, during their preparation. This polymer ligand has
already been proven as a good capping ligand for the synthesis
of cobalt and gold NPs by some of us.23,28,29
It is known that rapid injection of precursors results in super
saturation of chemical species in the reaction mixture which
leads to an initial burst of nucleation at once followed by the
growth of nuclei leading to the formation of monodisperse
inorganic NPs. Whereas, slow drop-wise addition of precursors
results in a continuous nucleation and growth processes in
parallel resulting in a broad size distribution of NPs.12,31,32
However, in the case of magnetite NPs, the process is more
complicated and difficult to control the nucleation and growth
processes as iron precursors are initially hydrolyzed under
alkaline conditions and then are condensed into iron oxide.
Therefore, we dissolved iron precursors in concentrated HCl
(38%) in order to avoid their hydrolysis and condensation prior
to the addition of precipitating agents.5 Both iron precursor
solution and ammonia were rapidly added into the boiling
aqueous solution of the polymer under a nitrogen atmosphere
with vigorous stirring in order to keep nucleation and growth
processes separate. Rapid injection of the precursor is widely
used for uniform inorganic NPs synthesis in the organic phase
by a thermal decomposition method.12–14,33 The preparation of
ultrasmall and uniform magnetic NPs with high crystallinity
and magnetization through the usual co-precipitation method
at room temperature is a tedious job, therefore we have carried
out a co-precipitation process at high temperature (100 C),19
which increases the reaction rate due to increased diffusion of
active species and thus results in the formation of NPs with a
narrow size distribution.19
The polymer ligand (DDT–PMAA) molecules cap the newly
formed NPs through an interaction between carboxylic acid
groups and the iron atoms on the NPs surface and thus restrict
their further growth by compensating the surface energy due to
electrostatic and steric stabilization which yields uniform as
well as highly stable NPs. We have already proved this hypoth-
esis by taking samples at different time intervals showing little
further growth of NPs with the passage of time.19 It was also
noticed that the use of a different ferrous precursor
(FeCl2$4H2O instead of FeSO4$7H2O) had no effect on the
shape, size and size distribution of the MIONs. Moreover, in
comparison to the thermal decomposition method, this
method involves no use of expensive and toxic organic precur-
sors or solvents but reduces the reaction time and temperature;
therefore it is more economical and eco-friendly.
The size of the magnetic NPs has two counter effects on their
properties and scope of applications. The MIONs with ultra-
small size (5–20 nm) are easy to disperse in solutions and show
higher stability against aggregation, however, they have very
small magnetic moments and therefore are unable to be
manipulated by an external magnetic eld and thus cannot be
used efficiently in certain applications such as magnetic sepa-
rations but still can be good candidates for other applications
like contrast agents for MRI.34 On the other hand, as the size of
magnetic NPs increases their magnetization is improved due to
their increased magnetic moments which make them more
attractive for magnetic separation applications; however, they
have poor dispersion capability and usually undergo aggrega-
tion. Thus, for any particular application, it is necessary to
prepare magnetic NPs with desired size and magnetic
properties.23
In this work, dried magnetic NPs prepared with DDT–PMAA
were re-dispersed in Milli-Q water to make aqueous dispersions
and without any size selection procedure hydrodynamic sizes of
magnetic NPs were determined by dynamic light scattering
(DLS) which are shown in (Fig. 1). It was observed from DLS
analysis that as the molecular weight of the polymer ligand is
gradually decreased, the size of the MIONs is steadily increased
(Fig. 1a–d). It may be attributed to the inefficient capping of
growing iron oxide nuclei by smaller polymer molecules
(Fig. 1d). However, using four different molecular weight poly-
mers, the size of the NPs was initially decreased with an
increase in the concentration of the polymer ligand but then the
size of NPs was increased again. This may be due to the better
diffusion of all these polymers at lower, but still enough,
concentration to approach the surface of growing nuclei of iron
oxide thus capping them at the earlier stage and limiting their
growth. At higher polymer concentration, the diffusion of
chemical species is restricted due to high viscosity of the
solution and thus allowing the iron oxide nuclei to grow into
larger NPs.19
In order to determine the size of MIONs, transmission
electron microscopy (TEM) was also performed for selected
samples which showed smaller diameter compared to that
obtained by DLS analysis. TEM analysis showed that MIONs
Fig. 1 DLS curves of MIONs prepared with different concentrations of (a) 0.5%
DDT–PMAA (b) 2% DDT–PMAA (c) 5% DDT–PMAA and (d) 10% DDT–PMAA.
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prepared with 1.5 mM 0.5% DDT–PMAA (Mn ¼ 14 624 g mol1)
were in the size range of ca. 5.1 0.8 nm (Fig. 2a) which is much
smaller than their hydrodynamic diameter obtained from DLS
(Fig. 1a). In the case of MIONs prepared with 1.5 mM 2% DDT–
PMAA (Mn ¼ 5330 g mol1), the hydrodynamic diameter
obtained from DLS was 5.9 nm (Fig. 1b) while its diameter
obtained from TEM was found to be 4.6  0.7 nm (Fig. 2b). It is
noteworthy that the actual size of theMIONs obtained with TEM
was much smaller than the hydrodynamic radii obtained from
the DLS method, which can be attributed to the presence of the
extended layer of the hydrated polymer ligand around these NPs
when dispersed in aqueous media and was also observed by Sun
and co-workers.35 Similarly, MIONs prepared with 1.5 mM 5%
DDT–PMAA (3123 g mol1) had a hydrodynamic diameter of
30 nm (Fig. 1c) but the actual diameter obtained from TEM was
found to be 5.0  1.0 nm (Fig. 2c). As the molecular weight of
the polymer is further decreased to 2281 g mol1, in the case of
10% DDT–PMAA, an intense increase in the size of NPs (over
100 nm) was observed by DLS analysis (Fig. 1d). It was inter-
esting to note that the increase in polymer concentration did
not help in reducing the size of MIONs obtained with 10%DDT–
PMAA (Fig. 1d). However, TEM analysis of these MIONs
obtained with 10% DDT–PMAA (1.5 mM) (Fig. 2d) revealed that
this increase in size is due to massive agglomeration of the
smaller NPs i.e., 4.7 to 5.9 nm. MIONs obtained with 10% DDT–
PMAA were not very well dispersed in aqueous solution and
were settled down within a few days due to their large
agglomeration rate and thus settling down under the force of
gravity. These results revealed that in addition to the concen-
tration of the polymer ligand (carboxylic acid groups to iron
precursor ratio), the molecular weight or in other words the
length of the polymer molecular chain is another important and
critical factor in determining the size and size-distribution of
the MIONs. TEM images and size distribution histograms of all
the MION samples prepared with different concentrations and
molecular weights of DDT–PMAA are provided in the ESI
(Fig. S2–S5†).
In order to study the surface chemistry of MIONs, they were
characterized by Fourier transform infrared spectroscopy
(FTIR). The comparison of FTIR spectra of 2% DDT–PMAA,
MIONs prepared with (1.5mM) 2%DDT–PMAA and bareMIONs
(without any capping ligand) is shown in Fig. S6.† The FTIR
spectrum of the polymer ligand has a strong absorption peak at
1704 cm1 corresponding to the asymmetric stretching of the
carbonyl (–CO–) group of the polymer ligand, which is exten-
sively reduced in the spectrum of MIONs with polymer which
indicates that the polymer is bound to the surface of iron oxide
NPs.36 Additionally a broad peak at 3124 cm1 is attributed to
the O–H stretching of carboxylic acid groups and is observed in
FTIR spectra of DDT–PMAA and MIONs@DDT–PMAA but
completely absent in the case of bare MIONs.28,37 Furthermore,
the asymmetric and symmetric stretching bands of carboxylate
(–COO–) present in the pure polymer ligand spectrum are shif-
ted from 1485 and 1390 to 1556 and 1402 cm1 respectively in
the spectrum of MIONs protected with a polymer ligand which
conrms the presence of a polymer ligand on the NPs surface.
Finally, the characteristic peaks appearing at 592 and 448 cm1
are assigned to the torsion vibration and stretching mode of the
Fe–O bond of magnetite present only in FTIR spectra of MIONs
with DDT–PMAA and bare MIONs.19,38
The crystalline structure of the MIONs was determined by
XRD measurement as shown in Fig. S7†. It can be clearly seen
that the peaks present at 2q ¼ 30.1, 35.5, 43.3, 53.4, 57.3 and
62.7 corresponding to (220), (311), (400), (422), (511) and (440)
reections of magnetite, respectively indicate the presence of
the crystalline spinel structured magnetite (Fe3O4) phase of iron
oxide.39 The wide peak at 2q ¼ 18.7 is assigned to the polymer
which was also found in the XRD pattern of the neat polymer
(data not shown).8 However, the phase of the iron oxide in
magnetic NPs cannot be conrmed by simple FTIR and XRD
because they are less sensitive to it.19 Therefore Raman spectra
of the magnetic NPs prepared in the presence/absence of
nitrogen were recorded (Fig. S8†). A characteristic peak of
magnetite at 665 cm1 is present in the Raman spectrum
(Fig. S8b†) which is signicantly reduced in intensity in the case
of oxidized iron oxide NPs indicating themajor iron oxide phase
to be Fe3O4.40 Furthermore, the peaks present at 384, 471, and
587 cm1 in the Raman spectrum (Fig. S8a†) are characteristic
peaks for maghemite (g-Fe2O3) which are absent in the
magnetite Raman spectrum. The formation of stable hematite
(a-Fe2O3) from maghemite (g-Fe2O3) by oxidation is indicated
by the appearance of strong peaks at 209 and 268 cm1 in the
maghemite Raman spectrum (Fig. S8a†).19,40–42
To further investigate the thermal stability of the MIONs,
and to deduce the iron oxide and polymer contents of the NPs,
thermogravimetric analysis was performed for 2% DDT–PMAA,
MIONs with 2% DDT–PMAA (1.5 mM) and bare MIONs. The
neat polymer ligand (2% DDT–PMAA) was almost completely
decomposed at 540 C with almost no residue le. From TGA
Fig. 2 (a) TEM images along with particle size distribution histograms of MIONs
prepared with 1.5 mM of 0.5% DDT–PMAA (a), 2% DDT–PMAA (b), 5% DDT–
PMAA (c) and 10% DDT–PMAA (d).
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analysis, we concluded that the polymer wt% in the MIONs with
2% DDT–PMAA (1.5 mM) was 70% and iron oxide wt% was 30%
(Fig. S9†).
Saturation magnetization of the selected samples of MIONs
prepared with different DDT–PMAA ligands was determined by
a Vibrating Sample Magnetometer (VSM) at room temperature.
In order to calculate the exact magnetization of these MIONs,
the effect of magnetically dead polymer layer was excluded and
then compared with magnetization of bare MIONs without the
polymer (Fig. S10†). The corrected magnetization of the MIONs
with 2% DDT–PMAA (1.5 mM) having a TEM diameter about 4.6
nm was found to be 50 emu g1 which is comparable to the
literature for MIONs of comparable dimensions.19 The low
saturation magnetization of 4.6 nm MIONs compared to the
bare MIONs is due to their ultra-small size as saturation
magnetization of magnetic NPs is directly related to their size.43
Dried MIONs prepared with 0.5, 2 and 5% DDT–PMAA were
highly stable and readily re-dispersible in water. pH and salt
stability tests were performed with aqueous dispersions of
MIONs prepared with 2% DDT–PMAA (1.5 mM) and were found
to be stable within a wide range of pH (05–10) and up to high
concentration of salt (NaCl) concentration (1 M) (Fig. S11†).
High stability of the MION dispersions can be attributed to the
large negative zeta potential and excellent electrostatic as well
as steric stabilization by the polymer ligand owing to the large
abundance of carboxylic acid groups.
3.3 Toxicity analysis and bioapplication of MIONs
In vitro cytotoxicity tests of the MIONs and polymer ligands
demonstrated that both polymer and polymer stabilized MIONs
were non-toxic to the cells even when used up to very high
concentration (1000 mg mL1).
However the MIONs without any polymer ligands showed
signicant toxicity towards cells, and reduced the cell viability
in a time dependent and dose dependent manner when their
concentration was exceeded beyond 25 mg mL1 (Fig. 3 and
S12†). This may be due to the fact that MIONs without polymer
ligand are quite large in size and more irregular in shape
compared to MIONs@DDT–PMAA which may be responsible
for cellular toxicity. Moreover, bare MIONs act as a source of
ferrous ions and highly reactive hydroxyl radicals which are
toxic to the cells.44
With the increase in concentration of these bare MIONs, cell
viability was further reduced even more promptly for a longer
exposure duration and at MION concentrations of 500 and 1000
mg mL1, and cell survival rates were lower than 50% (Fig. S12†).
On the other hand, the polymer ligand itself and MIONs capped
with the polymer ligand are totally biocompatible due to the
biocompatible nature of the polymer ligand (DDT–PMAA). The
optical micrographs of the cells for 24 h incubation time (Fig. 4)
show almost no decrease in cell density with the increasing
concentration of DDT–PMAA and MIONs@DDT–PMAA (Fig. 4,
top and middle rows respectively). While a noticeable decrease
in cell density can be seen with an increase in concentration of
bare MIONs (Fig. 4, bottom row). Bare MIONs have a large size,
broad size distribution (10  3 nm) and irregular shape
(Fig. S13†). Since they are not stabilized with any capping
ligand, they tend to aggregate and gather around the cells
posing oxidative and mechanical stress to the cells and
restricting their growth. When the concentrations of bare
MIONs are very high (200–1000 mg mL1), cell viability is
reduced up to 30% and the cells are heavily surrounded by NP
aggregates which makes it difficult to distinguish between the
cells and MION aggregates (Fig. 4, bottom row). These results
conrm that, in contrast to bare MIONs, the polymer ligand and
MIONs capped with the polymer ligand are non-toxic and very
biocompatible. Similarly, the cell viability of HepG2 was also
determined by MTT-assay aer 24, 48 and 72 h of incubation
with MIONs@2% DDT–PMAA and they were found to be non-
toxic to HepG2 even up to high concentrations (Fig. S14†).
MIONs prepared with DDT–PMAA have special characteris-
tics such as high water solubility and large negative zeta
potential and excellent stability in a wide range of pH and salt
concentrations, which make them highly suitable for bio-
applications such as contrast agents for MRI, magnetic sepa-
ration of biomolecules and cells, and development of NP based
drug delivery systems. Furthermore, the presence of abundant
carboxylic acid groups (–COOH) on the MIONs surface also
provide great opportunities to simultaneously modify these NPs
with targeting, tracing and therapeutic agents for multipurpose
bio-probes.
In order to explore the applications of MION@DDT–PMAA in
drug delivery, they were conjugated with doxorubicin (Scheme
1) and their zeta potential measurement indicated the presence
of drug on MIONs. The zeta potential value of the MIONs before
drug loading was as low as60mV because of abundant surface
carboxylic acid groups of the polymer capping ligand (Fig. 5).
However, loading of DOX resulted in an increase in zeta
potential of MIONs. In the case of covalent conjugation of the
drug, some of the surface carboxylic acid groups on the MIONs
undergo coupling reaction with amine groups of the drug
Fig. 3 Cell viability of rat macrophages determined by MTT-assay after 24 h
incubation with various concentrations of bare MIONs, DDT–PMAA and
MIONs@DDT–PMAA.
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molecules resulting in an increase in zeta potential of the nal
conjugate (35 mV). However, in the case of electrostatic
loading, the relatively small increase in the zeta potential (48
mV) indicates lower drug loading compared to that achieved by
covalent coupling.45
The conjugation of the DOX to the MIONs is also evidenced
from the FTIR spectra of DOX–MIONs (Fig. 6). The FTIR spec-
trum of pure DOX shows peaks at 3456 and 3335 cm1 which
are due to N–H stretching vibrations of the primary amine
structure and O–H stretching vibrations (Fig. 6a) respectively.
Whereas in the case of DOX-conjugated polymer coated MIONs,
these peaks are overlapped, broadened and are shied to the
lower frequency range (3260 cm1).46 Furthermore, the peaks
observed at 868 and 807 cm1 due to N–Hwag in pure DOX were
reduced in the FTIR spectrum of DOX-conjugated MIONs and a
characteristic band of Fe–O was appeared (Fig. 6b). Similarly,
the appearance of the other characteristic peaks of the pure
DOX was also observed in the FTIR spectrum of the DOX–
MIONs and collectively this evidence conrms the covalent
conjugation of the drug to the MIONs.
UV-visible spectra of DOX, MIONs and their conjugates and a
standard curve of DOX are presented in Fig. S15.† Drug–NP
conjugates were magnetically separated from the reaction
mixture as shown in Fig. S16† and were redispersed in the
buffer again. The DOX concentration in supernatant uids as
well as in redispersed conjugate solutions was determined from
the standard UV-visible standard curve equation. Drug loading
efficiencies of drug–NP conjugates were calculated to be 60%
and 57% for covalent (DOX–MIONs) and (DOX/MIONs) elec-
trostatic drug–NP conjugates respectively. TEM examination
showed no signicant change in size and size distribution of
individual particles except a little aggregation (Fig. S17†).
The cytotoxicity of drug and NP conjugates was determined
on HepG2 (human hepatoblastoma) cells through MTT-assay at
different time intervals i.e. aer 24, 48 and 72 h as shown in
Fig. 7. In vitro cytotoxicity of DOX and MIONs were indirectly
Fig. 4 Optical microscopic images of the cells growing with different concentrations of DDT–PMAA (top row), MIONs@DDT–PMAA (middle row) and bare MIONs
(bottom row) taken after 24 h of the incubation time period.
Fig. 5 Zeta potentials of MIONs, DOX–MIONs and DOX/MIONs in PBS (10 mM,
pH 7.4). Each result represents the mean of three runs with S.D.
Fig. 6 FTIR spectra of pure DOX (a) and DOX–MIONs (b).
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speculated from cell viability in the presence of free DOX and its
conjugates with MIONs. In these experiments, DOX is used as a
positive control and the % cell viability was calculated consid-
ering cell viability of the samples treated with no DOX as 100%.
It was observed that in all cases (free DOX, DOX–MIONs, and
DOX/MIONs), the activity of the drug was found to be dose as
well as time dependent. Cell viability of the HepG2 cells was
gradually decreased with increase in the drug concentration (mg
mL1). It is clearly evidenced that in all cases, cell viability of the
HepG2 cells is decreased with an increased exposure to DOX in
the cell medium either in the form of free DOX or its conjugate
with MIONs. These results are logical and in consistent with the
previous results.45
Aer 24 h, the anti-cancer activity of free DOX was observed
to be more prominent (Fig. 7a) i.e. cell viability was reduced to
50%, which can be attributed to the higher cellular uptake of
drug through simple diffusion,45 since it has been well estab-
lished in the literature that the pure doxorubicin is taken up by
the cells only through Fickian diffusion.47,48 However in the case
of DOX–MIONs and DOX/MIONs, the cellular uptake of the drug
was carried out more likely through endocytosis. It means that
conjugation of the drug with NPs facilitated the cellular uptake
of DOX through endocytosis which was probably not the case
with the free drug.45,49 Thus, aer 24 h, it was observed that free
DOX showed higher activity while its covalent conjugates with
MIONs showed reduced activity.
However, later on (inMTT-assays performed at 48 and 72 h of
incubation time) free DOX had less cytotoxicity whereas DOX/
MIONs showed the maximum activity as shown in Fig. 7b and c.
The higher activity of the DOX/MIONs may be attributed to the
more efficient cellular uptake of drug at later stages through
endocytosis as compared to the simple diffusion of free DOX.
The higher cytotoxicity activity of the drug and NP conjugates
(DOX–MIONs and DOX/MIONs) can also be attributed to the
higher solubility of these conjugates at physiological tempera-
ture and pH as compared to that of the free DOX.
The anti-cancer activity of the DOX–MIONs was higher than
that of free DOX but less than that of DOX/MIONs which is due
to the fact that DOX is known to chelate with DNA inside the
nucleus and arrest the cell functions causing cell death. Since,
in DOX–MION conjugates, the DOX is linked covalently to the
MIONs so probably it is not easily released inside the cytoplasm
and thus its transport to the nucleus is restricted. However, in
the case of DOX/MIONs, since the DOX is linked to the MIONs
only through electrostatic interactions, once inside the cell, the
DOX is easily released from conjugates under the chemical
environment within the cytoplasm and is available to penetrate
within the nucleus of the cell and chelate to DNA to arrest its
functions and cause cell death.50
To summarize, this work demonstrates the synthesis of the
highly water-soluble MIONs which can be easily conjugated to
DOX covalently or electrostatically with high drug loading effi-
ciency. The DOX/MIONs were observed to have higher cytotox-
icity than DOX–MIONs and free DOX possibly due to their
efficient cellular uptake through endocytosis compared to
passive diffusion. The exact mechanism of cellular uptake of
NPs is, however, a complex phenomenon and needs extensive
exploration. From cytotoxicity analysis and the behaviour of
DOX conjugated MIONs, it was observed that they have poten-
tial bio-applications owing to their excellent water solubility,
high stability and biocompatibility. Moreover, they possess a
chemically enriched surface for an easy conjugation with the
biomolecules, biomarkers, and therapeutic agents of choice for
their subsequent applications in MRI, multimodal imaging,
and drug delivery.
4 Conclusions
Biocompatible ultra-small magnetic iron oxide (Fe3O4) NPs
were prepared by co-precipitation of an aqueous iron precursor
solution at high temperature in the presence of a water-soluble
thioether end-functionalized polymer ligand DDT–PMAA.
These MIONs are fairly uniform in size and can be dried by
solvent evaporation so that it could be stored for a long time.
The dried powders of MIONs are readily re-dispersible in water
without any signicant change in their size and size
Fig. 7 Cell viability of HepG2 cells incubated with DOX–MIONs and DOX/MIONs
and free DOX with an equivalent DOX concentration determined after (a) 24 h,
(b) 48 h, and (c) 72 h. Each data point represent the mean  S.D. of three
experiments.
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distribution. MIONs aqueous dispersion was highly stable even
at high salt concentrations and also over a wide range of pH.
The molecular weight and concentration of the polymer ligand
showed a signicant effect on the size and magnetic properties
of MIONs.
MIONs were found to be highly biocompatible as deter-
mined by MTT-assay. The bio-applicability of MIONs was
demonstrated by developing NP based anti-cancer drug
conjugates. DOX was used as a model drug and its amine
groups were conjugated to the carboxylic acid groups of MIONs
through electrostatic and covalent interactions to prepare
DOX/MIONs and DOX–MIONs respectively. NPs and drug
conjugates showed high drug loading efficiency and demon-
strated higher cytotoxicity towards HepG2 cancer cells due to
their improved solubility and cellular uptake compared to the
free drug. It was observed that the drug loading mode can
signicantly affect the drug efficiency and this study can help
in the optimization of development of the MIONs based drug
delivery formulations. Furthermore, MIONs stabilized with
DDT–PMAA have rich surface chemistry which can be exploited
for the conjugation of a variety of therapeutic, targeting, and
labelling agents for several bio-analytical and drug delivery
applications.
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40 D. L. A. de Faria, S. Venâncio Silva and M. T. de Oliveira, J.
Raman Spectrosc., 1997, 28, 873–878.
41 K. N. Jallad and D. Ben-Amotz,Mater. Sci. Technol., 2001, 17,
1479–1486.
42 U. Schwertmann and R. M. Cornell, in Iron Oxides in the
Laboratory, Wiley-VCH Verlag GmbH, 2007, pp. 27–54.
43 A. Demortière, P. Panissod, B. P. Pichon, G. Pourroy,
D. Guillon, B. Donnio and S. Bégin-Colin, Nanoscale, 2011,
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